Head-to-head comparisons of medication uses, side effects, warnings, and more.
Victoza (liraglutide)
Wegovy (semaglutide)
Victoza (liraglutide)
Wegovy (semaglutide)
Summary of Victoza vs. Wegovy
Summary for GLP-1 agonist
Prescription only
Victoza (liraglutide) is a medication that's injected once a day. It helps lower blood sugar levels in people 10 years and older with Type 2 diabetes when used with a nutritious diet and regular exercise. It can also help lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. Victoza (liraglutide) belongs to the drug class called GLP-1 agonists. The medication comes as single-dose prefilled pens and is injected under the skin. It can cause side effects like nausea, vomiting, diarrhea, and constipation. Victoza (liraglutide) is available as both a brand-name and generic medication.
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that's injected under the skin. It's used together with a lower-calorie diet and regular exercise. Wegovy (semaglutide) is approved to help with weight loss in certain adults and children 12 years of age and older. It also helps lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The dosing schedule for the injections is once a week. Common side effects include nausea, diarrhea, and stomach pain.
Indications of Victoza vs. Wegovy
Indications for
•Type 2 diabetes in people age 10 and older, together with a balanced diet and exercise
•Lowering the risk of serious heart-related problems in adults with Type 2 diabetes and heart disease